Principle Health Systems, the leading mobile diagnostic provider for the long-term care community, is excited to announce its acquisition of Telos PGX, a pioneering force in pharmacogenetic testing. This strategic move will further accelerate Telos PGX’s mission to revolutionize healthcare by providing personalized medication solutions.
HealthTech Insights: Arintra’s Fully Automated Medical Coding Solution Now Available in Epic Toolbox
Telos PGX has rapidly gained recognition for its proprietary Telos PGX Program, specifically designed to support Skilled Nursing Facilities (SNFs) and enhance patient care.
By leveraging advanced pharmacogenetic testing, Telos PGX empowers healthcare providers to make precise medication decisions, reducing adverse drug reactions and optimizing treatment plans.
“We are thrilled to join forces with Principle Health Systems,” said D.J. Hart, Founder and CEO of Telos PGX. “This transaction will provide us with the resources and expertise to scale our operations, accelerate innovation, and expand our reach. Together, we will transform the future of healthcare and improve the lives of countless patients.”
HealthTech Insights: UMass Memorial Health Integrates AEYE Health’s AEYE-DS Autonomous AI
D.J. Hart will continue to play a pivotal role in the organization as he joins the leadership team at Principle Health Systems as the Director of Pharmacogenetic Operations. His deep understanding of the challenges faced by SNFs and his commitment to driving positive change will be instrumental in shaping the future of personalized medicine.
HealthTech Insights: Gozio Health and Hyro Partner to Bring AI Assistants
“Telos PGX’s innovative approach to pharmacogenetic testing aligns perfectly with our vision to deliver advanced healthcare solutions,” said James Dieter, CEO at Principle Health Systems. “By combining Principle’s experience and resources with Telos’s innovation, we will be able to accelerate the adoption of personalized medicine and improve patient outcomes.”
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – Prnewswire